Back
Vertex Pharmaceuticals Stock Price Chart
Sponsored
VRTX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
VRTX
Vertex Pharmaceuticals
Last Price:
450.53
Seasonality Move:
11.1%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing selling pressure, which indicates risk of future bearish movement.
Vertex Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 463.98 | Sell |
20-day SMA: | 477.93 | Sell |
50-day SMA: | 473.88 | Sell |
200-day SMA: | 453.97 | Sell |
8-day EMA: | 461.92 | Sell |
20-day EMA: | 472.05 | Sell |
50-day EMA: | 474.74 | Sell |
200-day EMA: | 452.65 | Sell |
Vertex Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.14 | Sell |
Relative Strength Index (14 RSI): | 38.12 | Sell |
Chaikin Money Flow: | -690526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (459.98 - 494.52) | Sell |
Bollinger Bands (100): | (464.62 - 492.24) | Sell |
Vertex Pharmaceuticals Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vertex Pharmaceuticals Stock
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 450.97 while VRTX 8-day simple moving average is 463.98, which is a Sell signal.
- The stock price of VRTX is 450.97 while Vertex Pharmaceuticals 20-day SMA is 477.93, which makes it a Sell.
- Vertex Pharmaceuticals 50-day simple moving average is 473.88 while VRTX share price is 450.97, making it a Sell technically.
- VRTX stock price is 450.97 and Vertex Pharmaceuticals 200-day simple moving average is 453.97, creating a Sell signal.
VRTX Technical Analysis vs Fundamental Analysis
Sell
47
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy or a Sell?
-
Vertex Pharmaceuticals stock is rated a Sell
The current Vertex Pharmaceuticals [VRTX] share price is $450.97. The Score for VRTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Vertex Pharmaceuticals Stock Info
Market Cap:
116.14B
Price in USD:
450.97
Share Volume:
1.26M
Vertex Pharmaceuticals 52-Week Range
52-Week High:
519.88
52-Week Low:
346.29
Sell
47
Vertex Pharmaceuticals (VRTX)
is a Sell
Vertex Pharmaceuticals Share Price Forecast
-
What is the Vertex Pharmaceuticals stock price today?
The Vertex Pharmaceuticals stock price is 450.97 USD today. -
Will VRTX stock go up or go down?
Vertex Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Vertex Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vertex Pharmaceuticals is overvalued.
Is Vertex Pharmaceuticals Stock a Buy?
- Vertex Pharmaceuticals share price is 450.97 while VRTX 8-day exponential moving average is 461.92, which is a Sell signal.
- The stock price of VRTX is 450.97 while Vertex Pharmaceuticals 20-day EMA is 472.05, which makes it a Sell.
- Vertex Pharmaceuticals 50-day exponential moving average is 474.74 while VRTX share price is 450.97, making it a Sell technically.
- VRTX stock price is 450.97 and Vertex Pharmaceuticals 200-day simple moving average is 452.65, creating a Sell signal.
Fundamental Analysis of Vertex Pharmaceuticals
Is Vertex Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.25 per share.
Technical Analysis of Vertex Pharmaceuticals
Should I short Vertex Pharmaceuticals stock?
- VRTX Moving Average Covergence Divergence (MACD) indicator is -6.14, suggesting Vertex Pharmaceuticals is a Sell
- Vertex Pharmaceuticals Relative Strength Index (RSI) is 38.12, which suggest Vertex Pharmaceuticals is oversold
- The Bollinger Bands (25) for Vertex Pharmaceuticals is (459.98 - 494.52), which suggest Vertex Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Vertex Pharmaceuticals is (464.62 - 492.24), which suggest Vertex Pharmaceuticals is a Sell
* Vertex Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.